HEPA a clinical stage biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis today announced the pricing of its underwritten public offering of 44200000 shares of its common stock at a public offering price of 200 per share for gross. A high-level overview of Hepion Pharmaceuticals Inc.
Hepion Pharmaceuticals Stock Quote Hepa Stock Price News Charts Message Board Trades
News Cramer Debt Offering Defense Dividend Dow Jones Industrial Average Downgrade Earnings Economic Data Energy.
Hepa stock news. HEPA stock at Seeking Alpha. HEPA stock quote history news and other vital information to help you with your stock trading and investing. NASDAQ Updated May 13 2021 1033 PM HEPA 156 001 064.
HEPA stock price news historical charts analyst ratings and financial information from WSJ. 11 rijen HEPA Stock Analysis Overview What this means. Advertentie Plus500 Buy and Sell Share CFDs From Your Home.
View real-time stock prices and stock quotes for a full financial overview. Get the latest news and real-time alerts from Hepion Pharmaceuticals Inc. 72 of retail lose money.
Access numerous financial markets from one place. Hepion Pharmaceuticals Inc. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.
Get the latest Hepion Pharmaceuticals Inc HEPA real-time quote historical performance charts and other financial information to help you make more informed trading and investment decisions. 72 of retail lose money. Hepion Pharmaceuticals Inc.
See All A Rated Buy Stocks Filter HEPA News Items All News Types Featured Stories Acquisition Airline Automobiles Barrons Biotechnology Buffett BusinessConsumer Services Buyback Commentary Commodities Consumer Goods Corp. Hepion Pharmaceuticals Inc. View live HEPION PHARMACEUTICALS INC chart to track its stocks price action.
Find market predictions HEPA financials and market news. NASDAQHEPA a clinical stage biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis NASH today announced the pricing of its underwritten public offering of 44200000 shares of its common stock. Find the latest Hepion Pharmaceuticals Inc.
Analyst estimates including HEPA earnings per share estimates and analyst recommendations. View the latest Hepion Pharmaceuticals Inc. Get Hepion Pharmaceuticals Inc HEPANASDAQ real-time stock quotes news price and financial information from CNBC.
HEPA Complete Hepion Pharmaceuticals Inc. Stock news by MarketWatch. Find the latest news headlines from Hepion Pharmaceuticals Inc.
Advertentie Plus500 Buy and Sell Share CFDs From Your Home. Find the latest analyst research for Hepion Pharmaceuticals Inc. Access numerous financial markets from one place.
16 2021 GLOBE NEWSWIRE -- Hepion Pharmaceuticals Inc.
